Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03584100 · ClinicalTrials.gov registry record · NA
Effect of Pneumatic Tourniquet on Arm Swelling After Lymph Node Removal
A NA study of Healthy Subject, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
- 1
- Study location
NCT03584100: Completed NA study of Healthy Subject, sponsored by Stanford University.
NCT03584100 is a NA study of Healthy Subject that has completed, run by Stanford University. The registered enrollment target is 12 participants, below the 247-participant average among 16 other Healthy Subject trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03584100, a NA study of Healthy Subject, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the proposed study is to evaluate the acute impact of swelling caused by low-pressure tourniquet use in the setting of ipsilateral prior axillary lymph node dissection and the change in swelling reduction following tourniquet use in three limb postures versus healthy volunteers.
Primary Outcome
Hand volume, as an indicator of limb edema / fluid accumulation, was determined with an aqueous volumeter at rest and for the sling and elevated arm positions 30 minutes after an arm tourniquet was placed. Measurements were taken for the affected arm \[ie, after axillary lymph node dissection (ALND)\], and the same patient's contralateral arm (control, ie, "other arm"). The mean values for each arm (affected vs control) of the participant group, before (baseline) and 30 minutes after placement
Conditions Studied
Interventions
- DEVICE Tourniquet 8000
Study Locations (1)
California
- Stanford University School of Medicine - Palo Alto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2018-11-07 |
| Est. Completion | 2020-06-30 |
| Phase | NA |
What the finished NCT03584100 record still lists
NCT03584100 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 247-participant average among 16 other Healthy Subject trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Healthy Subject appearing as the primary indexed condition, and to 1 intervention - of which Tourniquet 8000 is the first listed.
NCT03584100 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03584100 about?
NCT03584100 is a clinical study titled "Effect of Pneumatic Tourniquet on Arm Swelling After Lymph Node Removal". The purpose of the proposed study is to evaluate the acute impact of swelling caused by low-pressure tourniquet use in the setting of ipsilateral prior axillary lymph node dissection and the change in swelling reduction following tourniquet use in three limb postures versus healthy volunteers.
What is the current status of trial NCT03584100?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2018-11-07. Estimated completion is 2020-06-30.
What conditions does trial NCT03584100 study?
This clinical trial studies the following conditions: Healthy Subject.
What interventions are being tested in trial NCT03584100?
The interventions under investigation include: Tourniquet 8000 (DEVICE).
Who is sponsoring clinical trial NCT03584100?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03584100 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy Subject
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03584100's enrollment target sits among peer trials
12 16th of 16 higher than 1 of 16 other Healthy Subject trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy Subject trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Photoacoustic Imaging of the Breast in Patients With Breast Cancer and Healthy Subjects
RECRUITING · NA
-
Combined Breast MRI and Biomarker Strategies in Identifying High-risk Breast Cancer Patients
ACTIVE NOT RECRUITING · NA
-
Physical Activity in Promoting Smoking Cessation in African Americans
ACTIVE NOT RECRUITING · NA
-
Eat, Move, Live Intervention in Reducing Chronic Disease Risk in Medically Vulnerable Communities
ACTIVE NOT RECRUITING · NA
-
Tu Salud Si Cuenta Intervention in Increasing Physical Activity and Healthy Eating Among Latino Families
ACTIVE NOT RECRUITING · NA
-
Effects of Alternative Healthy Eating Index-Based Diet on Inflammatory Markers and Breast Density in Healthy Participants
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI